TheraGenetics Licenses Intellectual Property Related To Predicting Patient Response To Antidepressant Therapy

July 14th, 2008 | Category: Depression

TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system

(CNS) disorders, announced that it has completed an agreement with the Centre for

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Funding For Development Of OSU Technologies
  • Placebo Effect May Explain Relapse From Antidepressant Medication
  • How To Move Cancer Research Forward: Public/Private Partnerships - A NCI Science Writer’s Seminar
  • Researchers May Have Found analysis For Depression
  • A New Discovery Could Change Future Diagnosis And Therapy Of Depression

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.